Search Results - "Stampfli, H F"

Refine Results
  1. 1

    Biochemical properties of blood esmolol esterase by Quon, C Y, Stampfli, H F

    Published in Drug metabolism and disposition (01-07-1985)
    “…The blood esterase mediating the hydrolysis of esmolol was characterized in several different species including man. In contrast to most ester-containing…”
    Get more information
    Journal Article
  2. 2

    Species differences in the stereoselective hydrolysis of esmolol by blood esterases by Quon, C Y, Mai, K, Patil, G, Stampfli, H F

    Published in Drug metabolism and disposition (01-05-1988)
    “…The stereoselective hydrolysis of esmolol was examined in blood from several species including humans. Blood esmolol esterase activity was in the order of…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Biochemical characterization of flestolol esterase by Quon, C Y, Stampfli, H F

    “…The blood esterase that mediates the metabolism of flestolol, an ultra short-acting beta blocker, was characterized. Esterase activity occurred in plasma of…”
    Get more information
    Journal Article
  5. 5

    Tissue distribution of N-acetylprocainamide in rats by Yacobi, A, Stampfli, H F, Lai, C M, Kamath, B L

    Published in Drug metabolism and disposition (01-05-1981)
    “…The purpose of this study was to determine the distribution of N-acetylprocainamide (NAPA) in heart, kidney, and liver tissues of rats and their relationship…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Age-related pharmacokinetics of N-acetylprocainamide in rats by Yacobi, A, Kamath, B L, Stampfli, H F, Look, Z M, Lai, C M

    Published in Journal of pharmaceutical sciences (01-07-1983)
    “…The pharmacokinetics of N-acetylprocainamide, administered orally or intravenously, were studied in 3-, 6-, and 12-month-old rats using a two-way crossover…”
    Get more information
    Journal Article
  8. 8

    An evaluation of 2-benzyl-1-naphthol (DuP 654) analogs as systemic anti-inflammatory agents by Kerr, J S, Batt, D G, Pinto, D J, Stampfli, H F

    “…DuP 654 (2-benzyl-1-naphthol) is a topically active anti-inflammatory agent that was evaluated in phase II clinical trials as an anti-psoriatic agent. The…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Survival of Bone Marrow-Engrafted Mice Subsequent to Protection from Lethal Radiation by WR 2721 by Kinnamon, Kenneth E., Ketterling, Lyle L., Ledney, G. David, Lorenz, Gregory B., Mioduszewski, Robert J., Stampfli, Herman F.

    Published in Radiation research (01-04-1980)
    “…For the first time data are presented for animals treated with bone marrow cells after lethal radiation exposure while protected with WR 2721 (the single…”
    Get full text
    Journal Article
  11. 11

    Polymorphic metabolism of flestolol and other ester containing compounds by a carboxylesterase in New Zealand white rabbit blood and cornea by Stampfli, H F, Quon, C Y

    “…Flestolol, N(1,1-dimethyl-2-ureidocthyl)-2-hydroxy-3-(o-fluorobenzoyloxy++ +) propylamine, (F), is an ester containing an ultra short-acting beta blocker…”
    Get more information
    Journal Article
  12. 12

    Ester derivatives of 2,6-bis(1-pyrrolidinylmethyl)-4-benzamidophenol as short-acting antiarrhythmic agents. 1 by Stout, David M, Black, Lawrence A, Barcelon-Yang, Cynthia, Matier, W. L, Brown, Barry S, Quon, Check Y, Stampfli, Herman F

    Published in Journal of medicinal chemistry (01-08-1989)
    “…In an effort to find a replacement for the iv antiarrhythmic drug lidocaine having reduced systemic and central nervous system effects, activity against…”
    Get full text
    Journal Article
  13. 13

    [(Arylcarbonyl)oxy]propanolamines. 1. Novel .beta.-blockers with ultrashort duration of action by Kam, Sheung Tsam, Matier, William L, Mai, Khuong X, Barcelon-Yang, Cynthia, Borgman, Robert J, O'Donnell, John P, Stampfli, Herman F, Sum, Check Y, Anderson, William G

    Published in Journal of medicinal chemistry (01-08-1984)
    “…Novel [(arylcarbonyl)oxy]propanolamines were synthesized and investigated as potential ultrashort-acting beta-adrenergic receptor blockers. Many of these…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Mono- and bis(aminomethyl)phenylacetic acid esters as short-acting antiarrhythmic agents. 2 by Chorvat, Robert J, Black, Lawrence A, Ranade, Vasant V, Barcelon-Yang, Cynthia, Stout, David M, Brown, Barry S, Stampfli, Herman F, Quon, Check Y

    Published in Journal of medicinal chemistry (01-08-1993)
    “…The synthesis, antiarrhythmic activity, and blood hydrolysis properties of a series of mono- and bis(aminomethyl)phenylacetic acid esters related to a…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Pharmacodynamics and onset of action of esmolol in anesthetized dogs by Quon, C Y, Gorczynski, R J

    “…The pharmacodynamics and onset of action of esmolol, a novel, cardioselective beta adrenergic receptor antagonist with an ultra short duration of action, were…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Tissue distribution of [14C]bretylium tosylate in rats by Yacobi, A, Kamath, B L, Lai, C M, Stampfli, H F

    Published in Journal of pharmaceutical sciences (01-05-1983)
    “…The distribution of [14C]bretylium tosylate in the body and the relationship between tissue and plasma concentrations was determined following intravenous…”
    Get more information
    Journal Article
  20. 20

    Pharmacokinetics of [14C]bretylium tosylate in rats by Kamath, B L, Stampfli, H F, Lai, C M, Yacobi, A

    Published in Journal of pharmaceutical sciences (01-06-1981)
    “…The pharmacokinetics of bretylium tosylate were investigated in eight male Charles River rats. Each animal received an intravenous dose (10 mg/kg) of…”
    Get more information
    Journal Article